Learn how Claude's ability to monitor its internal states could transform AI safety and provide insights into human brain ...

Kairos Pharma Ltd. , a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, provides an overview of key 2025 milestones and outlook into 2026 in a Letter to Shareholders ...

Sparkle Clean Tech (SCT) (exclusive global licensee of Siemens Energy's oil & gas water-treatment IP) and Aquadei, LLC have formed a strategic alliance to deploy Aquadei's proprietary nanobubble and ...

This year for the first time, the ESET Science Award was open to researchers in the humanities. Two of the winners – including yourself – have this background. How relevant would you say the topic of ...

Good afternoon, and welcome to Sarepta's Third Quarter 2025 Financial Results Conference Call. As a reminder, today's program is being recorded. At this time, I'll turn the call over to Tam Thornton, ...

Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...

Researchers uncovered a 2.75–2.44 million-year-old site in Kenya showing that early humans maintained stone tool traditions for nearly 300,000 years despite extreme climate swings. The tools, ...

We must resist the temptation to reinterpret the Bayh-Dole Act even in an effort to improve the affordability of and access ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, ...

But study also warns that current threats to agencies that track such data risks future progress and global competitiveness ...

A calendar of virtual and IRL gatherings, including resources for founders, networking opportunities and more.

Delivered Q3 2025 revenue of $83 million Q3 2025 non-dermatologic revenue increased by 67% over Q3 2024 Q3 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) ...